Nikolaos Ioannou

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis.

Progressive T cell defects correlate with disease outcome in high-count monoclonal B-cell lymphocytosis.

Journal: Leukemia

Published: March 10, 2025

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.

Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial.

Journal: Blood

Published: March 23, 2023

Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.

Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemia.

Journal: Haematologica

Published: November 22, 2022

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

The immunomodulatory molecule TIGIT is expressed by chronic lymphocytic leukemia cells and contributes to anergy.

Journal: Haematologica

Published: October 10, 2022

Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.

Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses.

Journal: Blood cancer discovery

Published: February 24, 2022

Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.

Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.

Journal: Leukemia

Published: September 15, 2021

Immunomodulatory Drugs for the Treatment of B Cell Malignancies.

Immunomodulatory Drugs for the Treatment of B Cell Malignancies.

Journal: International journal of molecular sciences

Published: June 20, 2021

Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.

Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.

Journal: Immunity

Published: January 09, 2021

Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.

Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.

Journal: Leukemia

Published: November 08, 2020

A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice.

A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient Mice.

Journal: Frontiers in immunology

Published: November 07, 2020

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Journal: Frontiers in oncology

Published: November 06, 2020

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Journal: Oncology reports

Published: July 15, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026